Jun Wang

iCarbonX engages in the provision of digital health records by storing genomic, and medical and daily health data services. The firm offers individualized health analysis and prediction of health index through advanced data mining and machine analysis technologies. The company was founded on by Haoli, Yingrui Li, Jun Wang, and Chun Wu on October 28, 2015 and is headquartered in Shenzhen, China.

AOBiome LLC develops and commercializes skin care products. The firm operates an application of AOB that has the potential to restore critical biological and biochemical processes through the symbiotic relationship between humans and this naturally-existing bacteria to address significant clinical need. It has six ongoing clinical programs in acne vulgaris, or acne, allergic rhinitis, migraine, atopic dermatitis, or eczema, rosacea and hypertension, and multiple ongoing preclinical programs, including pulmonary and gastrointestinal disorders. The company was founded by Jamie Heywood, Lenny Barshack, Spiros Jamas, and David Whitlock in 2013 and is headquartered in Cambridge, MA.

BGI Biotech (Shenzhen) Co., Ltd. engages in the conducting of biotechnology. Its business scope includes development, manufacture, and wholesale and retail of medical equipment. The company was founded on November 26, 2013 and is headquartered in Shenzhen, China.

AOBiome Therapeutics, Inc. develops microbiome-targeted therapies for local, nasal and systemic inflammatory conditions. Its portfolio includes three clinical-stage programs, a Phase 2b study to treat patients with acne vulgaris, a Phase 2 trial to reduce elevated blood pressure, and a Phase 1b/2a clinical trial in allergic rhinitis, as well as earlier-stage preclinical programs targeting diverse inflammatory indications. The company was founded by Jamie Heywood, David Whitlock and Lenny Barshack in 2013 and is headquartered in Cambridge, MA.

PatientsLikeMe LLC operates online health communities for patients. The firm offers data and information on patients, treatments, symptoms and research. The company was founded by Benjamin Heywood, James Heywood and Jeff Cole in 2004 and is headquartered in Cambridge, MA.

SomaLogic Operating Co., Inc. engages in the development of technologies used in the areas of diagnostics, clinical research, and pharmaceutical development. It offers protein biomarker systems for applications in drug discovery, therapeutic treatments, and wellness monitoring. The firm's products and services include SOMAscan service, SOMAscan at the institution, individual SOMAscan reagents, SOMAmer discovery service, SomaLogic CLIA laboratory, and technical support. The company was founded by Larry Gold and David Brunel in 2000 and is headquartered in Boulder, CO.